Retrospective study evaluating safety, clinical effect, and dosing of dalteparin for the treatment of venous thromboembolism in term neonates

Documenti analoghi

• Epidemiology of clinically unsuspected venous thromboembolism in children with cancer: A population‐based study from Maritimes, Canada
  di: Brett Ells, et al.
  Pubblicazione: (2024)
• Sequelae and post‐thrombotic syndrome after venous thromboembolism in acute lymphoblastic leukemia survivors treated on the NOPHO ALL2008 protocol
  di: Merete Dam, et al.
  Pubblicazione: (2024)
• Results of a long‐term, prospective study on complications of central venous catheter in pediatric patients with hematologic‐oncologic diseases
  di: Chiara Garonzi, et al.
  Pubblicazione: (2024)
• Immunologic hemolytic anemia associated with neonatal alloimmune thrombocytopenia caused by HLA antibody in a male neonate
  di: Yuichi Kubo, et al.
  Pubblicazione: (2024)
• Adequate menstrual suppression in adolescents with inherited bleeding disorders often requires multiple treatment changes: Retrospective cohort study of a multidisciplinary clinic
  di: Megan C. Brown, et al.
  Pubblicazione: (2024)